HALOZYME THERAPEUTICS, INC.

Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.

HALO | NDAQ

Overview

Corporate Details

ISIN(s):: US40637H1095
LEI:
Country:: United States of America
Address:: 12390 EL CAMINO REAL, 92130 SAN DIEGO
Website:: https://www.halozyme.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Halozyme Therapeutics, Inc. is a biotechnology company focused on its proprietary drug delivery technology platform, ENHANZE®. This technology facilitates the subcutaneous (under-the-skin) delivery of injectable drugs and biologics that are often administered intravenously. Halozyme licenses its ENHANZE® technology to global biopharmaceutical companies, enabling them to develop new formulations of their therapies. This model aims to reinvent the patient experience by reducing treatment burden and shortening administration times, particularly in therapeutic areas such as oncology. The company's commercial portfolio is primarily built on royalties and milestone payments derived from its partners' sales of products utilizing the ENHANZE® platform.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HALOZYME THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HALOZYME THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for HALOZYME THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Soiken Holdings Inc. A bioscience group offering clinical testing, supplements, and cosmetics for pharma/food industries.	Japan	2385
Sotkamo Silver AB Mines silver, gold, and zinc in Finland to supply essential metals for green technologies.	Sweden	SOSI
Stagwell Inc A digital-first marketing network transforming brands with data, media, and creative services.	United States of America	STGW
Star Equity Holdings, Inc. A diversified holding co. in building, talent solutions, energy services, and investments.	United States of America	STRR
Stem Cells Spin Spolka Akcyjna Biotech firm commercializing proprietary MIC-1 stem cells through R&D, cultivation, and production.	Poland	SCS
STRANGER HOLDINGS PLC Mining and developing uranium and strategic metals with near-term production projects in Africa.	United Kingdom	STHP
Ströer SE & Co. KGaA A media company providing integrated out-of-home (OOH) and digital advertising solutions.	Germany	SAX
STUDIO ALICE Co.,Ltd. Specialized photo studios capturing family milestones with costumes, styling, and kimono rentals.	Japan	2305
Surrozen, Inc./DE Develops regenerative antibodies modulating the Wnt pathway to repair tissues and restore organs.	United States of America	SRZN
SUSMED, Inc. Develops digital therapeutics (DTx) and AI systems to streamline clinical development.	Japan	4263